Moderna, Inc.
Company Stats
- Market Cap
- $76.9B
- as of Sep 30, 2026
- Shares Outstanding
- 399.2M
- Free Float
- 81.3%
Income Statement
- Revenue
- $1.9B
- Operating Income
- -$3.1B
- Net Income
- -$2.8B
- EBITDA
- -$2.9B
- Revenue Growth, 3Y
- -53.4%
- FCF Margin, 3Y Avg
- -95.8%
- FCF Margin, Worst Year
- -125.3%
Cash Flow
- Free Cash Flow
- -$2.1B
- FCF Yield
- -2.7%
- Owner FCF Yield
- -3.3%
Balance Sheet
- Cash & Equivalents
- $2.6B
Returns & Capital
- Share Repurchases
- $2.0M
- Buyback Yield, 3Y Avg
- 0.5%
- SBC, 3Y Avg
- $405.7M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $1.9B | -$2.1B | -106.2% |
| FY2024 | $3.2B | -$4.1B | -125.3% |
| FY2023 | $6.8B | -$3.8B | -55.9% |
| FY2022 | $19.3B | $4.6B | 23.8% |
| FY2021 | $18.5B | $13.3B | 72.2% |
Annual filing data through FY ended December 31, 2025; shares and float as of October 13, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges
Healthcare Earnings: Demand Surges, Costs Bite Back